4.7 Letter

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020

期刊

CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 71, 期 7, 页码 1787-1794

出版社

SPRINGER
DOI: 10.1007/s00262-022-03145-0

关键词

Immunotherapy; Cancer vaccines; Checkpoint blockade agents; Adoptive immunotherapy; Targeted therapies; NIBIT

资金

  1. AstraZeneca
  2. Becton Dikinson
  3. Bristol Meyers Squibb
  4. Diatech Labline
  5. Fuidigm
  6. Incyte
  7. Merck Sharp and Dome (MSD)
  8. Milteny Biotech
  9. Nano String
  10. Novartis
  11. Pierre Fabre Oncology
  12. Promega
  13. AIOM
  14. Associazione Italiana Oncologia Toracica (AIOT)
  15. Fondazione Associazione Italiana per la Ricerca sul Cancro (AIRC)
  16. ACC
  17. Fondazione Melanoma onlus
  18. Fondazione Grazia Focacci
  19. Istituto Oncologico Veneto (IOV)
  20. Fondazione Pezcoller
  21. SIC
  22. SIICA
  23. Women for Oncology Italy

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据